Primis Financial (FRST) Earnings Analysis
Primis Financial (FRST) next reports earnings on 2026-07-23, consensus EPS 0.3811 USD. Last quarter (2026-04-23) it beat with EPS 0.33 USD vs 0.32 USD est (+3.1%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E 8.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FRST next report earnings?
| Next earnings date | 2026-07-23 |
|---|---|
| Consensus EPS estimate | 0.3811 USD |
| Revenue estimate | 0.05B |
FRST earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 0.33 USD | 0.32 USD | +3.1% | Beat |
| 2026-01-29 | 0.1 USD | 0.34 USD | -70.6% | Miss |
| 2025-10-23 | 0.28 USD | 0.32 USD | -12.5% | Miss |
| 2025-07-24 | 0.11 USD | 0.24 USD | -54.2% | Miss |
| 2025-01-28 | -0.65 USD | 0.11 USD | -690.9% | Miss |
| 2024-10-24 | 0.08 USD | 0.43 USD | -81.4% | Miss |
| 2024-07-25 | 0.32 USD | 0.39 USD | -17.9% | Miss |
Beat rate: 1/7 (14%) over reported quarters with consensus data.
FRST valuation and analyst view
| Trailing P/E | 8.38 |
|---|---|
| Trailing EPS | 1.87 USD |
| Price / book | 0.91 |
| Dividend yield | 2.54% |
| Market cap | 0.39B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 19 USD |
Related research pages
Frequently asked questions
When is Primis Financial (FRST)'s next earnings date?
Primis Financial is next scheduled to report on 2026-07-23, with a consensus EPS estimate of 0.3811 USD and revenue estimate of 0.05B.
Did FRST beat earnings last quarter?
In its 2026-04-23 report, FRST posted EPS of 0.33 USD versus a 0.32 USD estimate — a beat of 3.1%.
What is FRST's earnings track record?
Over the last 7 reported quarters with consensus data, FRST beat estimates 1 times (14%).
What is FRST's current P/E ratio and EPS?
FRST trades at a trailing P/E of 8.38 on trailing EPS of 1.8698146941835947 USD.
What do analysts rate FRST?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 19 USD.